A Swiss Pharmaceutical Specialty-Care Group

We focus on solutions in the field of Haematology, Oncology, Nephrology, Cardiology, Infectious Disease and Rare Disease

Bildschirmfoto 2025-05-07 um 11.41.47
sqr031-col1
sqr031-col2

About Us

WHAT WE ARE

IDEOGEN is a Swiss, family-owned pharmaceutical company that provides solutions for patients, payers and caregivers to access Specialty Care therapies in the fields of Haematology, Oncology, Nephrology, Cardiology, and Infectious Diseases and Rare/Orphan Diseases.

What We Do

  • Support international pharma companies to commercialise their products in Specialty & Salvage Care therapies from Unlicensed to Licensed Market Access.

  • 360° Medico-Marketing of Specialty Pharmaceutical Products from Regulatory& MarketAccess support to Commercialization, thereby providing partners a platform to access key Regulated Markets.

  • Investment in Co-Development of late-stage R&D through to Commercialization in specific Therapy Areas.

OUR CAPABILITIES

  • We Live & Breathe life sciences.
  • We make the Complex Simple.
  • We adhere to the Highest Standards.
  • We deliver Patient-Centric solutions.
  • We invest in Relationships.